申请人:Sandoz Ltd.
公开号:US05510353A1
公开(公告)日:1996-04-23
Compounds of formula A--X--Y--NH--B wherein A is derived from optionally substituted benzothiophene, indole, 4-aza-and 7-aza-benzothiophene or-indole, A bearing in position 5 hydrogen, halogen, optionally substituted alkyl, hydroxy, nitro, amino, alkylamino, acylamino, alkoxycarbonyl, sulfamoyl, cyano, trimethylsilyl, carboxy, carbamoyl, phosphate, oxycarbamoyl, heterocyclic radical or ether or ester group, X-Y is --CR.sub.8 .dbd.N-- or CH(R.sub.8)--NH-- wherein R.sub.8 is -H or alkyl and attached at position 3 of A, and B is a heterocyclic radical or a residue ##STR1## wherein R.sub.10 is H, optionally substituted alkyl, cycloalkyl, aryl, adamantyl, acyl or carbamoyl and X.sub.2 is alkylthio or NR.sub.3 R.sub.10 wherein R.sub.3 is H or alkyl or R.sub.3 and R.sub.10 together with the nitrogen atom to which they are attached form a heterocyclic radical, in free form or in salt form, have pharmacological activity, e.g. for treating gastrointestinal disorders.
化合物的分子式为A--X--Y--NH--B,其中A来源于可选择取代苯并噻吩、吲哚、4-氮杂苯并噻吩或7-氮杂苯并噻吩或吲哚,A在位置5带有氢、卤素、可选择取代的烷基、羟基、硝基、氨基、烷基氨基、酰基氨基、烷氧基羰基、磺酰胺基、氰基、三甲基硅基、羧基、氨基甲酰基、磷酸酯基、氧羰基甲酰基、杂环基或醚或酯基,X-Y为--CR.sub.8 .dbd.N--或CH(R.sub.8)--NH--,其中R.sub.8为-H或烷基,连接在A的位置3上,B为杂环基或残基##STR1##,其中R.sub.10为H、可选择取代的烷基、环烷基、芳基、金刚烷基、酰基或氨基甲酰基,X.sub.2为烷基硫或NR.sub.3 R.sub.10,其中R.sub.3为H或烷基,或R.sub.3和R.sub.10与它们连接的氮原子形成杂环基,以自由形式或盐形式具有药理活性,例如用于治疗胃肠疾病。